Insights on pharma shipping, dry ice science, regulatory compliance, and the future of predictive cold chain monitoring.
Three different industry publications ran the same thesis this month. The shift from after-the-fact logging to real-time intervention isn't hypothetical anymore.
USB loggers tell you what already happened. Active monitoring tells you what's happening now. That distinction is reshaping how pharma ships its most critical products.
Most shippers think GDP compliance means downloading USB logger data after delivery. Auditors see right through that.
The physics are well understood. So why does the entire industry ship billions in product with zero visibility into whether the dry ice is still there?
A patient died because someone forgot to plug a freezer back in. $35 billion lost annually. But most of the damage never makes the reports.
I've seen shipments arrive with zero dry ice left. The temp logger showed everything was fine. That's the problem.